This is the first study, to our knowledge, examining the ability of PPARγ activation to induce differentiation markers and to antagonize the TGF-β1-mediated changes associated with the EMT process in a human squamous carcinoma cell line. This evidence concerns the gene TGFB1 and squamous cell carcinoma.